10x Insights
Loading account…
Companies / Health Care / QT Imaging Holdings, Inc.
QTI

QT Imaging Holdings, Inc.

Health CareElectromedical Apparatus
Ticker QTINOVATO, CAFiscal year ends DecemberBook value per share $0.16Diluted shares 14.3M

QT Imaging Holdings, Inc. is a medical device company developing innovative body imaging systems using low-energy transmitted sound waves. The company's website is www.qtimaging.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$18.93M
+287.9% year over year
Last 12 mo $26.43M
-23.45%
+226.2 percentage points
Last 12 mo -24.84%
$-21.08M
−134.6% year over year
Last 12 mo $-20.42M
-327.12%
−421.3 percentage points
Last 12 mo -909.24%
Cash & financing
$-8.96M
+10.7% year over year
Last 12 mo $-12.47M
$-9.08M
+10.3% year over year
Last 12 mo $-12.74M
0.71
Was -0.93× a year earlier
Last 12 mo 6.81
10.5M
−47.6% year over year
Last 12 mo 14.3M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What QT Imaging Holdings, Inc. does

In the company’s own words

QT Imaging Holdings, Inc. is a medical device company developing innovative body imaging systems using low-energy transmitted sound waves. The company's website is www.qtimaging.com.

Founded in 2012 as QT Ultrasound LLC and incorporated as QT Imaging, Inc. in Delaware in 2020, the company completed a business combination with special purpose acquisition company GigCapital5, Inc. in March 2024, resulting in the current parent holding company structure. QT Imaging is headquartered in Novato, California.

The company's core product is the Breast Acoustic CT scanner, a Class II medical device cleared by the FDA under Section 510(k) for breast imaging applications. The technology generates high-resolution three-dimensional volumetric images of breast tissue using ultra-low frequency transmitted and reflected sound waves without ionizing radiation or breast compression. The company received initial FDA clearance in June 2017 and subsequent clearances in August 2022 for quantitative breast tissue measurements and in March 2026 for enhanced posterior breast tissue imaging coverage.

QT Imaging's technology addresses limitations of conventional imaging modalities such as mammography, MRI, and CT by eliminating radiation exposure, avoiding patient discomfort from compression, and reducing infrastructure requirements. The company has received approximately $181 million in financial support from the U.S. National Institutes of Health for research and development.

The company operates through a hybrid commercialization model combining direct sales with strategic partnerships. A key distribution partnership exists with NXC Imaging, Inc., a subsidiary of Canon Medical Systems Corporation, which serves as the exclusive reseller in the United States and U.S. territories. The company is also expanding internationally through distribution partnerships in the Gulf Cooperation Council region, including the Kingdom of Saudi Arabia and United Arab Emirates, with plans to pursue European and other international markets.

Beyond hardware, QT Imaging is developing a cloud-based software-as-a-service platform designed to deliver quantitative imaging biomarkers and artificial intelligence-driven diagnostic support. The company aims to transition from a hardware manufacturer to a precision imaging platform combining hardware, software, and cloud-based artificial intelligence modules for clinical interpretation and quantitative imaging analysis.

Company details
Sector
Health Care
Industry (SIC)
Electromedical Apparatus
Headquarters
NOVATO, CA
Fiscal year end
December
CIK
1844505
SIC
3845

Financial performance, year by year

Fiscal 2022–2025 · USD
$-25.83M$-11.58M$2.67M$16.93M$31.18M2022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns QT Imaging Holdings, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

9
funds hold it
0 of 35
superinvestors hold it
$2.17M
held by funds, at market
3.5%
of shares held by funds

Largest fund holders · QT Imaging Holdings, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
0.00%of fund net assets
Fidelity Total Market Index Fund
FSKAX · Fidelity Concord Street Trust
0.00%of fund net assets
Fidelity Series Total Market Index Fund
FCFMX · Fidelity Concord Street Trust
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do QT Imaging Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of QT Imaging Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in QT Imaging Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.